Digital Pathology News
Lunit said Tuesday that it has published research showing that its AI biomarker platform, Lunit SCOPE, can improve HER2 (human epidermal growth factor receptor 2) diagnosis in advanced bile duct cancer. The study was published in Laboratory...
From the blog at Indica Labs As we reach the end of 2025, the Indica Labs team extends our sincere thanks to the customers and collaborators who helped make this year one of remarkable innovation, growth, and scientific achievement. We are...
INFINITT North America, a leader in advanced healthcare imaging solutions, is excited to announce the newest addition to its digital pathology platform: the FDA-cleared Hamamatsu NanoZoomer S360MD Slide Scanner, now seamlessly integrated...
Albuquerque, NM, December 17, 2025 – Indica Labs, the global leader in AI-powered digital pathology, announced today that clinical revenue for HALO AP® is up 260% since 2023 and recurring revenue for 2025 shows a 200% increase...
Aiforia expands its AI technology platform featuring the powerful Vision Transformer architecture and proprietary Foundation Engine. Aiforia Technologies Plc, Press Release, December 17, 2025 at 9:00 a.m. EET Aiforia Technologies Plc...
Collaboration to leverage Lunit SCOPE IO ® and SCOPE universal IHC® (uIHC) digital pathology products in two Daiichi Sankyo oncology research and development programs SEOUL, South Korea, Dec. 15, 2025 /PRNewswire/ -- Lunit (KRX:328130),...
